Lv761
5000 积分 2022-02-14 加入
Immune evasion strategies in AFP-producing gastric carcinoma: characterized by HLA-G expression and HLA class I deficiency
3天前
已完结
Gastric Cancer With Primitive Enterocyte Phenotype
3天前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
8天前
已完结
BCMA T-cell engager therapy in patients with refractory autoimmune disease
8天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
17天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已完结
Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset
1个月前
已完结
Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab
1个月前
已完结
Traditional laboratory parameters and IFNγ-related biomarkers in the diagnosis and management of MAS
1个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
2个月前
已完结
皖公网安备34019202002308
